BMT CTN Protocol 0301

Fludarabine-based Conditioning for Allogeneic Marrow Transplantation from HLA-compatible Unrelated Donors in Severe Aplastic Anemia

Below are protocol-related documents, which may be periodically updated.

            Protocol Chair:  Paolo Anderlini, MD (713-794-5743) panderli@mail.mdanderson.org

            Protocol Officer:  Mary Eapen, MD (414-805-0700) meapen@mail.mcw.edu

            Protocol Coordinator: Iris Gersten, MS (301-251-1161) igersten@emmes.com

            Medical Monitor: Chris Bredeson, MD cbredeson@ohri.ca

 

This study reached target accrual and was closed to patient accruals on December 2, 2013.